BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Asthika Goonewardene does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 BNTXBioNTech SE | Buy | $155.00 | Jun 2025 | −33.1% | Miss |
 LEGNLegend Biotech Corp | Buy | $71.00 | May 2025 | −9.9% | Miss |
 ALLOAllogene Therapeutics Inc | Buy | $10.00 | May 2025 | +83.1% | Miss |
 GMABGenmab AS | Buy | $45.00 | Mar 2025 | +27.9% | Miss |
 IOVAIovance Biotherapeutics Inc | Buy | $15.00 | Mar 2025 | −12.0% | Miss |
 ACLXArcellx Inc | Buy | $136.00 | Nov 2024 | −15.9% | Miss |
 STROSutro Biopharma | Buy | $15.00 | Aug 2024 | −70.0% | Miss |
 HOOKHookipa Pharma Inc | Buy | $4.00 | Sep 2023 | −43.2% | Miss |
| HOOKHookipa Pharma Inc | Buy | $4.00 | Mar 2023 | −27.5% | Miss |
 NXTCNextCure Inc | Buy | $15.00 | Aug 2022 | −70.2% | Miss |
| HOOKHookipa Pharma Inc | Buy | $11.00 | Aug 2022 | −62.1% | Miss |
| NXTCNextCure Inc | Buy | $19.00 | Mar 2021 | −73.7% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.